These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10780253)

  • 1. Relationship of dopamine to serotonin in the neonatal 6-OHDA rat model of Lesch-Nyhan syndrome.
    Allen SM; Davis WM
    Behav Pharmacol; 1999 Sep; 10(5):467-74. PubMed ID: 10780253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supersensitization of the oral response to SKF 38393 in neonatal 6-hydroxydopamine-lesioned rats is eliminated by neonatal 5,7-dihydroxytryptamine treatment.
    Brus R; Kostrzewa RM; Perry KW; Fuller RW
    J Pharmacol Exp Ther; 1994 Jan; 268(1):231-7. PubMed ID: 8301563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced oral activity responses to intrastriatal SKF 38393 and m-CPP are attenuated by intrastriatal mianserin in neonatal 6-OHDA-lesioned rats.
    Plech A; Brus R; Kalbfleisch JH; Kostrzewa RM
    Psychopharmacology (Berl); 1995 Jun; 119(4):466-73. PubMed ID: 7480527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ontogenetic SKF 38393 treatments sensitize dopamine D1 receptors in neonatal 6-OHDA-lesioned rats.
    Gong L; Kostrzewa RM; Brus R; Fuller RW; Perry KW
    Brain Res Dev Brain Res; 1993 Nov; 76(1):59-65. PubMed ID: 8306431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.
    Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Crotty K; Mueller RA
    J Pharmacol Exp Ther; 1984 Nov; 231(2):343-54. PubMed ID: 6149306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin 5-HT2A but not 5-HT2C receptor antagonism reduces hyperlocomotor activity induced in dopamine-depleted rats by striatal administration of the D1 agonist SKF 82958.
    Bishop C; Daut GS; Walker PD
    Neuropharmacology; 2005 Sep; 49(3):350-8. PubMed ID: 15993442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supersensitized oral responses to a serotonin agonist in neonatal 6-OHDA-treated rats.
    Gong L; Kostrzewa RM
    Pharmacol Biochem Behav; 1992 Mar; 41(3):621-3. PubMed ID: 1584843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine and 5-HT receptor sensitivity does not correlate with neostriatal dopamine or 5-HT content.
    Kostrzewa RM; Brus R; Perry KW; Fuller RW
    Acta Neurobiol Exp (Wars); 1996; 56(1):21-8. PubMed ID: 8787176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dopamine deficiency model of Lesch-Nyhan disease--the neonatal-6-OHDA-lesioned rat.
    Breese GR; Criswell HE; Duncan GE; Mueller RA
    Brain Res Bull; 1990 Sep; 25(3):477-84. PubMed ID: 2127238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MIF-1 fails to modify agonist-induced oral activity in neonatal 6-OHDA-treated rats.
    Gong L; Kostrzewa RM; Kalbfleisch JH
    Peptides; 1993; 14(6):1159-64. PubMed ID: 7907787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of risperidone in the neonatal 6-hydroxydopamine model of Lesch-Nyhan syndrome.
    Allen SM; Freeman JN; Davis WM
    Pharmacol Biochem Behav; 1998 Feb; 59(2):327-30. PubMed ID: 9476977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proposed animal model of attention deficit hyperactivity disorder.
    Kostrzewa RM; Brus R; Kalbfleisch JH; Perry KW; Fuller RW
    Brain Res Bull; 1994; 34(2):161-7. PubMed ID: 7913871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-sensitization between footshock stress and apomorphine on self-injurious behavior and neostriatal catecholamines in a rat model of Lesch-Nyhan syndrome.
    Stodgell CJ; Loupe PS; Schroeder SR; Tessel RE
    Brain Res; 1998 Feb; 783(1):10-8. PubMed ID: 9479035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrastriatal serotonin 5-HT2 receptors mediate dopamine D1-induced hyperlocomotion in 6-hydroxydopamine-lesioned rats.
    Bishop C; Kamdar DP; Walker PD
    Synapse; 2003 Nov; 50(2):164-70. PubMed ID: 12923819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal dopamine depletion reveals a synergistic mechanism of mRNA regulation that is mediated by dopamine(D1) and serotonin(2) receptors and is targeted to tachykinin neurons of the dorsomedial striatum.
    Campbell BM; Gresch PJ; Walker PD
    Neuroscience; 2001; 105(3):671-80. PubMed ID: 11516832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supersensitization of the oral response to SKF 38393 in neonatal 6-OHDA-lesioned rats is mediated through a serotonin system.
    Gong L; Kostrzewa RM; Fuller RW; Perry KW
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1000-7. PubMed ID: 1602367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal-6-hydroxydopamine treatment: model of susceptibility for self-mutilation in the Lesch-Nyhan syndrome.
    Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Mueller RA
    Pharmacol Biochem Behav; 1984 Sep; 21(3):459-61. PubMed ID: 6436840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D1 receptor modulation of glutamate receptor messenger RNA levels in the neocortex and neostriatum of unilaterally 6-hydroxydopamine-lesioned rats.
    Rodríguez-Puertas R; Herrera-Marschitz M; Koistinaho J; Hökfelt T
    Neuroscience; 1999 Mar; 89(3):781-97. PubMed ID: 10199613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine re-uptake inhibitor GBR-12909 induction of aberrant behaviors in animal models of dopamine dysfunction.
    Loupe PS; Bredemeier JD; Schroeder SR; Tessel RE
    Int J Dev Neurosci; 2002; 20(3-5):323-33. PubMed ID: 12175869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.